An interesting read on an competitor (a one trick pony as opposed to CTIX) in the antibiotic space regarding a capital raise and potential uplisting:
http://www.fiercebiotech.com/biotech/motif-bi...otic-phiii

Anyone know anything about their antibiotic? I believe it failed once and they are bringing it back.